+

BR9809409B1 - mÉtodo para a preparaÇço de compostos tricarbonÍlicos metÁlicos faciais e a kits para preparaÇço de uma composiÇço de marcaÇço ou de uma composiÇço farmacÊutica diagnàstica ou terapÊutica. - Google Patents

mÉtodo para a preparaÇço de compostos tricarbonÍlicos metÁlicos faciais e a kits para preparaÇço de uma composiÇço de marcaÇço ou de uma composiÇço farmacÊutica diagnàstica ou terapÊutica.

Info

Publication number
BR9809409B1
BR9809409B1 BRPI9809409-2A BR9809409A BR9809409B1 BR 9809409 B1 BR9809409 B1 BR 9809409B1 BR 9809409 A BR9809409 A BR 9809409A BR 9809409 B1 BR9809409 B1 BR 9809409B1
Authority
BR
Brazil
Prior art keywords
preparation
compound
diagnostic
composition
pharmaceutical composition
Prior art date
Application number
BRPI9809409-2A
Other languages
English (en)
Other versions
BR9809409A (pt
Inventor
Roger Alberto
Roger Schibli
Andre Egli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9809409A publication Critical patent/BR9809409A/pt
Publication of BR9809409B1 publication Critical patent/BR9809409B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0476Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from monodendate ligands, e.g. sestamibi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0474Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G45/00Compounds of manganese
    • C01G45/04Carbonyls
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01GCOMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G99/00Subject matter not provided for in other groups of this subclass
    • C01G99/006Compounds containing a metal not provided for elsewhere in this subclass, with or without oxygen or hydrogen, and containing two or more other elements
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/004Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005Compounds without a metal-carbon linkage
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/88Isotope composition differing from the natural occurrence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI9809409-2A 1997-04-25 1998-04-21 mÉtodo para a preparaÇço de compostos tricarbonÍlicos metÁlicos faciais e a kits para preparaÇço de uma composiÇço de marcaÇço ou de uma composiÇço farmacÊutica diagnàstica ou terapÊutica. BR9809409B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97201232A EP0879606A1 (en) 1997-04-25 1997-04-25 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates
PCT/US1998/007979 WO1998048848A1 (en) 1997-04-25 1998-04-21 Method for the preparation of facial metal tricarbonyl compounds and their use in the labelling of biologically active substrates

Publications (2)

Publication Number Publication Date
BR9809409A BR9809409A (pt) 2000-06-13
BR9809409B1 true BR9809409B1 (pt) 2008-11-18

Family

ID=8228251

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809409-2A BR9809409B1 (pt) 1997-04-25 1998-04-21 mÉtodo para a preparaÇço de compostos tricarbonÍlicos metÁlicos faciais e a kits para preparaÇço de uma composiÇço de marcaÇço ou de uma composiÇço farmacÊutica diagnàstica ou terapÊutica.

Country Status (18)

Country Link
EP (2) EP0879606A1 (pt)
JP (1) JP4357597B2 (pt)
KR (1) KR100579168B1 (pt)
AT (1) ATE211924T1 (pt)
AU (1) AU748213B2 (pt)
BR (1) BR9809409B1 (pt)
CA (1) CA2282563C (pt)
CZ (1) CZ295214B6 (pt)
DE (1) DE69803205T2 (pt)
DK (1) DK1019095T3 (pt)
ES (1) ES2168751T3 (pt)
HU (1) HU225487B1 (pt)
IL (1) IL131658A (pt)
NO (1) NO995160L (pt)
NZ (1) NZ337303A (pt)
PL (1) PL189514B1 (pt)
PT (1) PT1019095E (pt)
WO (1) WO1998048848A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19860289C2 (de) 1998-12-21 2003-11-13 Schering Ag Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium
EP1021074B1 (en) 1999-01-15 2012-06-20 The Boeing Company Solid state flight deck panels and components thereof
US6844425B1 (en) 1999-02-24 2005-01-18 Mallinckrodt Inc. Combination of intercalating organometallic complexes and tumor seeking biomolecules for DNA cleavage and radiotherapy
CA2360419C (en) * 1999-02-24 2009-09-22 Mallinckrodt, Inc. Molecules for the treatment and diagnosis of tumours
US6926883B1 (en) * 1999-06-29 2005-08-09 Mallinckrodt Inc Group (VII) transition-metal complexes with multidentate aminopolycarboxylate ligands and a kit for producing them
JP2003503415A (ja) * 1999-06-29 2003-01-28 マリンクロッド・インコーポレイテッド 多座配位性アミノポリカルボキシレート配位子との7族遷移金属錯体およびその調製用キット
AUPQ262499A0 (en) 1999-09-02 1999-09-23 University Of Queensland, The Novel iron chelators
DE60041344D1 (de) * 1999-10-05 2009-02-26 Mallinckrodt Inc Carbonmonoxidquelle für die herstellung von übergangsmetallcarbonylkomplexe
US6359119B1 (en) * 2000-05-24 2002-03-19 Mallinckrodt Inc. Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate
AU7521001A (en) * 2000-06-02 2001-12-11 Regents Board Of Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
CN1136921C (zh) * 2001-04-27 2004-02-04 北京师范大学 一种心肌显像剂及其制备方法
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
CN1646140A (zh) 2002-02-04 2005-07-27 阿尔法玛药品研发有限公司 可释放co的化合物在用于治疗炎症药物的制备中的应用
KR100445971B1 (ko) * 2002-04-15 2004-08-25 한국원자력연구소 수소화붕소 교환수지를 이용한 테크네튬 또는 레늄의표지방법
AU2003268431B2 (en) * 2002-09-03 2008-12-04 University Of Zurich Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
ES2346974T3 (es) 2003-04-15 2010-10-22 Mallinckrodt Inc. Pirazolilo tridentado bifuncional que contiene ligandos para complejos de tricarbonilo re, tc y mn.
US7682601B2 (en) 2003-04-15 2010-03-23 Mallinckrodt Inc. Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
BRPI0409906A (pt) * 2003-04-29 2006-04-25 Univ Zuerich l-histidina protegida, metálica e orgánica derivatizada em nepsilon e/ou nalfa para acoplar ás biomoléculas para marcação altamente eficiente com [m(oh2)3(co)3]+ por coordenação de fac
CA2579355A1 (en) * 2004-09-07 2006-03-16 Michael J. Adam Synthesis of radiolabeled sugar metal complexes
JP2008037752A (ja) * 2004-11-19 2008-02-21 Nihon Medi Physics Co Ltd 新規放射性テクネチウム−ビスホスフィノアミン錯体および該錯体を含む放射性画像診断剤
KR100650506B1 (ko) * 2005-12-16 2006-11-30 한국원자력연구소 방사성 의약품용 레늄-트리카보닐 착물 및 그 전구체의제조방법
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
GB0623482D0 (en) 2006-11-24 2007-01-03 Mallinckrodt Inc Technetium-99m (l) tricarbonyl complexes with tridentate chelators for myocardium imaging
DE102010014412A1 (de) 2010-04-08 2012-04-19 Friedrich-Schiller-Universität Jena Verwendung von zweikernigen Eisenkomplexen mit schwefelhaltigen Liganden als pharmakologische Wirkstoffe
DE102010014411A1 (de) 2010-04-08 2011-10-13 Friedrich-Schiller-Universität Jena Kohlenmonoxid und Eisen freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
JP5978291B2 (ja) 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドAlfama,Inc. 一酸化炭素放出分子およびその使用
EP2734235B1 (en) 2011-07-21 2017-03-22 Alfama, Inc. Ruthenium carbon monoxide releasing molecules and uses thereof
DE102012004132A1 (de) 2012-02-29 2013-08-29 Friedrich-Schiller-Universität Jena Kohlenstoffmonoxid freisetzende Materialien und deren Verwendung
KR101200049B1 (ko) * 2012-05-14 2012-11-13 한국원자력연구원 테크네튬-99엠 트리카보닐 표지 글리신 단량체 또는 올리고머 활용 생리활성분자를 이용한 프로브의 제조방법 및 이를 포함하는 영상제 조성물
DE102014008537A1 (de) 2014-06-04 2015-12-17 Friedrich-Schiller-Universität Jena Wasserlösliche manganbasierte Kohlenstoffmonoxid freisetzende Moleküle, deren Verwendung und Verfahren zu deren Herstellung
RU2708076C1 (ru) * 2019-09-10 2019-12-04 федеральное государственное автономное образовательное учреждение высшего образования «Национальный исследовательский Томский политехнический университет» Способ получения комплекса технеция-99м с производным октреотида для диагностики нейроэндокринных опухолей

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533570B1 (fr) * 1982-09-23 1985-07-12 Centre Nat Rech Scient Complexes organometalliques d'oestrogenes et leur application au dosage des recepteurs hormonaux

Also Published As

Publication number Publication date
IL131658A (en) 2004-12-15
HUP0003255A3 (en) 2003-06-30
EP1019095A1 (en) 2000-07-19
AU748213B2 (en) 2002-05-30
JP2002512616A (ja) 2002-04-23
KR100579168B1 (ko) 2006-05-12
HUP0003255A2 (hu) 2001-02-28
DE69803205D1 (de) 2002-02-21
EP1019095B1 (en) 2002-01-16
JP4357597B2 (ja) 2009-11-04
NO995160L (no) 1999-12-13
CZ295214B6 (cs) 2005-06-15
CZ9903751A3 (en) 2001-05-16
AU7141398A (en) 1998-11-24
BR9809409A (pt) 2000-06-13
PT1019095E (pt) 2002-07-31
NZ337303A (en) 2000-12-22
PL336382A1 (en) 2000-06-19
PL189514B1 (pl) 2005-08-31
CA2282563A1 (en) 1998-11-05
DK1019095T3 (da) 2002-05-06
NO995160D0 (no) 1999-10-22
WO1998048848A1 (en) 1998-11-05
DE69803205T2 (de) 2002-09-19
HU225487B1 (en) 2006-12-28
CA2282563C (en) 2007-12-04
ES2168751T3 (es) 2002-06-16
EP0879606A1 (en) 1998-11-25
IL131658A0 (en) 2001-01-28
KR20010020298A (ko) 2001-03-15
ATE211924T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
BR9809409B1 (pt) mÉtodo para a preparaÇço de compostos tricarbonÍlicos metÁlicos faciais e a kits para preparaÇço de uma composiÇço de marcaÇço ou de uma composiÇço farmacÊutica diagnàstica ou terapÊutica.
US6126916A (en) Radiometal-binding peptide analogues
AU633859B2 (en) Improvements in or relating to organic compounds
US5183653A (en) Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds
JPH07103159B2 (ja) 放射性核種金属キレート
JP4365223B2 (ja) 放射性フッ素化方法
WO1989012625A1 (en) Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
Crocker et al. Heterobifunctional cross-linking agents incorporating perfluorinated aryl azides
Chen et al. Synthesis and characterization of the oxygen and desthio analogues of glutathione as dead-end inhibitors of glutathione S-transferase
Tamura et al. Identification of peptides with 5-dimethylaminonaph-thalenesulfonyl chloride
Storey et al. Polypeptides. LI. Application of S-ethylcarbamoylcysteine to the synthesis of a protected heptatetracontapeptide related to the primary sequence of ribonuclease T1
CA2019035C (en) Stabilized radiopharmaceutical compositions
Blok et al. New chelation strategy allows for quick and clean 99mTc-labeling of synthetic peptides
US5242680A (en) Thiol-reactive maleimido-based radiolabeling reagents
US5144043A (en) Cleavable bifunctional coupling agents
CA2070961C (en) Thiol-reactive maleimido-based radiolabeling reagents
KR960703612A (ko) 면역계 및 중추 신경계 치료용 신규의 트리펩티드(novel tripeptides useful in immune and cns therapy)
Okarvi et al. Comparison of the labelling characteristics of mercaptoacetyltriglycine (MAG3) with different S‐protective groups
CN112979509A (zh) 一种三氟甲磺酰基炔酰胺类化合物及其制备方法和用途
Everse et al. Investigations into the relationship between structure and function of diphtheria toxin.
Leighton et al. Amino Acid Sequences Containing Cysteine or Half-Cystine Residues in ß-Glucuronidase
Scheunemann et al. A simple and efficient synthesis of a derivatized pseudotripeptide containing a methylene thioether isostere and its use for the design of bifunctional rhenium and technetium chelating agents
SCHLEYER et al. Dependence of human somatotropin activity on interchain disulfide bridges
Saljoughian CHEMICAL BIODYNAMICS DIVISION
CZ507690A3 (en) Method of peptide radiolabelling

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 51/04, C07F 13/00, G01N 33/58, G01N

Ipc: A61K 51/04 (2007.01), C07F 13/00 (2007.01), G01N 3

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/12/2008, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: MALLINCKRODT LLC (US)

Free format text: NOME ALTERADO DE: MALLINCKRODT INC.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 02.12.2018

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载